Dr. Larson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
La Jolla, CA 92037Phone+1 858-657-7000Fax+1 619-543-6529
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2009 - 2011
University of Texas Southwestern Medical SchoolClass of 2009
Certifications & Licensure
CA State Medical License 2011 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency.Abraham T Phung, Jaimin R Shah, Tao Dong, Tony Reid, Christopher Larson
Breast Cancer Research. 2024-09-10 - 9 citationsROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourt...Tony R Reid, Nacer Abrouk, Scott Caroen, Bryan Oronsky, Meaghan Stirn
Clinical Colorectal Cancer. 2023-03-01 - 10 citationsBETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors.Santosh Kesari, Alberto Bessudo, Brian R Gastman, Anthony P Conley, Victoria M Villaflor
Future Oncology. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
